Showing results (701-710 of 712) with videos related to

Sort By:
Pageof 72
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 7, 2025
Wilms tumor characteristics in children with heterozygous germline DIS3L2 variantsS E van Peer, T D Treger, J Wegert, et al.
Nature Communications|August 19, 2022
SARS CoV-2 mRNA vaccination exposes latent HIV to Nef-specific CD8<sup>+</sup> T-cellsEva M Stevenson, Sandra Terry, Dennis Copertino, et al.
Genome Announcements|June 20, 2015
Genome Sequences of Cluster G Mycobacteriophages Cambiare, FlagStaff, and MOOREtheMARYerWelkin H Pope, David A Augustine, Daniel C Carroll, et al.
AIDS (London, England)|December 22, 2022
Antibody response durability following three-dose coronavirus disease 2019 vaccination in people with HIV receiving suppressive antiretroviral therapyHope R Lapointe, Francis Mwimanzi, Peter K Cheung, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 9, 2024
Sleeping Beauty mRNA-LNP enables stable rAAV transgene expression in mouse and NHP hepatocytes and improves vector potencyPhilip M Zakas, Sharon C Cunningham, Ann Doherty, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2022
People with HIV receiving suppressive antiretroviral therapy show typical antibody durability after dual COVID-19 vaccination, and strong third dose responsesHope R Lapointe, Francis Mwimanzi, Peter K Cheung, et al.
NPJ Vaccines|March 1, 2022
Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapyZabrina L Brumme, Francis Mwimanzi, Hope R Lapointe, et al.
The Journal of Infectious Diseases|June 7, 2022
People With Human Immunodeficiency Virus Receiving Suppressive Antiretroviral Therapy Show Typical Antibody Durability After Dual Coronavirus Disease 2019 Vaccination and Strong Third Dose ResponsesHope R Lapointe, Francis Mwimanzi, Peter K Cheung, et al.
Medrxiv : the Preprint Server for Health Sciences|October 21, 2021
Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapyZabrina L Brumme, Francis Mwimanzi, Hope R Lapointe, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|February 1, 2020
The cost-effectiveness of progesterone in preventing miscarriages in women with early pregnancy bleeding: an economic evaluation based on the PRISM trialC B Okeke Ogwulu, I Goranitis, A J Devall, et al.
Pageof 72